Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Research quality note: Supplier formula listings can vary by salt form, counter-ion, acetate/TFA form or documentation style
Specifications retained Specification control for FOXO4-DRI is especially important in comparative work
Related Topics Tirzepatide Deep Dive mechanism, clinical results, and comparison context Retatrutide vs Tirzepatide triple versus dual receptor comparison Semaglutide vs Tirzepatide direct comparison and evidence boundaries GLP-1 Dosing Optimizer split-frequency modeling and plasma curves Full Reconstitution Calculator all-peptide vial math and custom BAC volumes GLP-1 Lean Mass Guide protein, training, and body-composition evidence References Tirzepatide for non-diabetic obesity SURMOUNT-1, 72 weeks, 5/10/15 mg, weight -15.0/-19.5/-20.9% (treatment-regimen estimand), DXA and pulse in Table S7: Jastreboff NEJM 2022
Risks and Side Effects of GHK-Cu GHK-Cu exhibits minimal side effects and is well-tolerated in studies, with low oral and excellent subcutaneous bioavailability
For a dog with early-to-moderate arthritis, thats potentially meaningful
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
